Poor
Not Aligned
Patient Risk:
Moderate
Summary
Only one dosing-related claim is partially supported by label text; all other claims are absent from the supplied label sections, including multiple non-prescribing (pricing/discount/coverage/access) statements.
Category Scores
Accurate Statements
Podofilox should be used exactly as directed to avoid local tissue injury.
DOSAGE AND ADMINISTRATION: prescriber should ensure patient is aware of correct method of therapy; application on surrounding normal tissue should be minimized; more frequent application would be expected to increase local adverse reactions and systemic absorption; dosing cycle instructions provided.
Unsupported Statements
Podofilox is prescription-only in many places.
Absent from the label.
Podofilox products are sold in different formulations and concentrations.
Absent from the label.
Discounts for podofilox can come from coupons or savings cards from the manufacturer (if available) or pharmacy coupon programs.
Absent from the label.
Discounts for podofilox can come from price-shopping across pharmacies, where cash price can differ a lot even without insurance.
Absent from the label.
Insurance coverage tiers and prior-authorization rules can affect whether podofilox is covered.
Absent from the label.
Discount programs offered by large retailers and independent pharmacies can provide podofilox discounts.
Absent from the label.
A discount for podofilox may depend on the specific package size or strength.
Absent from the label.
When comparing podofilox offers, the formulation (cream vs solution) should match the prescribed product.
Absent from the label.
When comparing podofilox offers, the concentration should match the prescribed product.
Absent from the label.
When comparing podofilox offers, the bottle/tube size should match the prescribed product.
Absent from the label.
If insurance won’t cover podofilox or the copay is high, pharmacy discount pricing (cash price) may be sought.
Absent from the label.
If a generic version exists for the same formulation/strength, generic availability may reduce cost.
Absent from the label.
Therapeutic alternatives may be discussed with a clinician as a cost-saving option.
Absent from the label.
Contradictions
Important Omissions
Specific label administration instructions and limitations (e.g., twice daily for 3 consecutive days then discontinue for 4 consecutive days; repeat up to four cycles; discontinue if incomplete response after four cycles; limit to 10 cm^2 and no more than 0.5 g per day; minimize application to surrounding normal tissue; wash hands before/after; allow to dry; flammability/avoid open flame; avoid eye contact).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
The only partially supported claim is general use “as directed.” Multiple other statements are not supported by the provided label and do not reflect label-required safety/administration limitations.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Most claims are absent from the supplied FDA label text, including multiple access/cost/discount statements and product comparison guidance.
Suggested Improvement
Restrict claims to information actually present in the supplied label (e.g., dosing cycle, maximum treatment limits, minimizing normal tissue exposure, wash hands, avoid eye contact, and flammability precautions). Remove unsupported pricing/coverage/discount assertions.